Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
luca.maddaloni@uniroma1.it
Luca Maddaloni
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
luca.maddaloni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
The epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative women and men: a ten-year retrospective observational study in Rome (Italy)
PATHOGENS
2024
Virulence evaluation of Israeli Marek's disease virus isolates from commercial poultry using their meq gene sequence
VIRUS GENES
2024
The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy)
PATHOGENS
2024
Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with hiv
JOURNAL OF MEDICAL VIROLOGY
2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
MICROORGANISMS
2023
Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
PATHOGENS
2023
Cellular immune profiling of lung and blood compartments in patients with SARS-CoV-2 infection
PATHOGENS
2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
MICROORGANISMS
2023
Immune reconstitution and safe metabolic profile after the switch to bictegravir/emtricitabine/tenofovir alafenamide fumarate among virologically controlled plwh. A 96 week update from the bictel cohort
VIRUSES
2023
Differential expression of type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies
IMMUNITY, INFLAMMATION AND DISEASE
2023
Exploiting bacteria for improving hypoxemia of COVID-19 patients
BIOMEDICINES
2022
Health-related quality of life in survivors of severe covid-19 infection
PHARMACOLOGICAL REPORTS
2022
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2019
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
BMC PUBLIC HEALTH
2019
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma